The methodology presented in this document provides a way to efficiently estimate COVID-19 prevalence by analysing the results of pooled RT-PCR tests, without the need to identify individual test results. The statistical foundation of the methodology is explained in detail.
According to EU recommendations, timely and accurate COVID-19 laboratory testing is an essential part of the management of COVID-19 for slowing down the pandemic, supporting decisions on infection control strategies and patient management at healthcare facilities, and detecting asymptomatic cases that could spread the virus further if not isolated.
This report sets out the evidence on IGRAs and their use in the diagnosis of latent and active tuberculosis.After reviewing all available evidence, the expert panel concluded that ‘IGRAs should not replace the standard diagnostic methods for diagnosing active TB.’